Pharmacists’ essential knowledge on cognitive impairment in the elderly population
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Issue Date
2017-11-30
Metadata
Show full item recordAbstract
Background: There are various factors which can lead to irreversible, reversible cognitive impairments. The progression of reversible cognitive disorders can be halted by identifying and treating the underlying cause. Aim of the Review: To expand pharmacists’ knowledge on underlying causes of cognitive impairment and investigate the possibility of pharmacist involvement in the identification of and/or protection against cognitive impairment. Method: A search of the literature was conducted through databases to identify studies in the English language of 1975-2016. Peer-reviewed articles and informational websites were included. Results: There are two broad classifications of cognitive impairment, irreversible and reversible cognitive impairment. Pharmacists can play an essential role in early detection of cognitive impairment caused by medications. Conclusion: Pharmacists have the potential to lead early detection of cognitive impairment caused by medications through appropriate management of the underlying problem. This may contribute to patients’ better health outcomes and quality of life.Citation
Abed, H., Ball, P., Morrissey, H., (2017) 'Pharmacists’ essential knowledge on cognitive impairment in the elderly population' International Journal of Current Research, 9 (11), pp. 1-7.Journal
International Journal of Current ResearchAdditional Links
http://www.journalcra.com/article/pharmacists%E2%80%99-essential-knowledge-cognitive-impairment-elderly-populationType
Journal articleLanguage
enISSN
0975-833XCollections
The following licence applies to the copyright and re-use of this item:
- Creative Commons
Except where otherwise noted, this item's license is described as https://creativecommons.org/CC BY-NC-ND 4.0